Summary
Occlutech International AB (Occlutech) is a medical device company that develops and supplies heart implant products. The company's products include occluders, occlutech atrial flow regulator (AFR), accessory medical devices (AFR), among others. Atrial flow regulator (AFR) is a cardiac implant designed to address the needs of patients suffering from heart failure. It operates through research and development, and production facilities located in Germany, the UK, Italy, France, Benelux, the Nordics, Australia, New Zealand and Canada, among others. Occlutech is headquartered in Helsingborg, Sweden.This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Occlutech International AB
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Occlutech International AB Company Overview
- Occlutech International AB Company Snapshot
- Occlutech International AB Pipeline Products and Ongoing Clinical Trials Overview
- Occlutech International AB - Pipeline Analysis Overview
- Occlutech International AB - Key Facts
- Occlutech International AB - Major Products and Services
- Occlutech International AB Pipeline Products by Development Stage
- Occlutech International AB Ongoing Clinical Trials by Trial Status
- Occlutech International AB Pipeline Products Overview
- Dialysis Prosthesis Device
- Dialysis Prosthesis Device Product Overview
- Occlutech Atrial Flow Regulator (AFR) Device
- Occlutech Atrial Flow Regulator (AFR) Device Product Overview
- Occlutech Atrial Flow Regulator (AFR) Device Clinical Trial
- Occlutech Figulla Flex II ASD Occluder
- Occlutech Figulla Flex II ASD Occluder Product Overview
- Occlutech Figulla Flex II ASD Occluder Clinical Trial
- Occlutech Figulla Flex II PFO Occluder
- Occlutech Figulla Flex II PFO Occluder Product Overview
- Occlutech Figulla Flex II PFO Occluder Clinical Trial
- Occlutech Figulla Flex UNI
- Occlutech Figulla Flex UNI Product Overview
- Occlutech International AB - Key Competitors
- Occlutech International AB - Key Employees
- Occlutech International AB - Locations And Subsidiaries
- Head Office
- Recent Developments
- Occlutech International AB, Recent Developments
- Aug 28, 2024: Occlutech Announces Commercial Cases of Occlutech ASD Occluder Device Implantation in the U.S.
- Jan 08, 2024: Occlutech Announces FDA Approval of its Occlutech ASD Occluder and Occlutech Pistol Pusher, a Minimally Invasive Cardiac Device and Delivery System to Treat Atrial Septal Defects
- Sep 05, 2023: Occlutech Q2 2023 - Continued Strong Revenue Growth
- Mar 14, 2023: Occlutech begins subject enrolment in Atrial Flow Regulator trial
- Jan 31, 2023: Occlutech continues its progress in US FDA study OCCLUFLEX - enrolls first patient in Europe
- Aug 24, 2022: Occlutech Q2 2022 - Positive Revenue Growth and Important Milestones Achieved in the Strategic US Market
- May 12, 2022: Occlutech progress in US - First patient has been enrolled in important US FDA study
- Aug 16, 2021: Occlutech granted important conditional FDA approval for PFO Study (OCCLUFLEX) in the U.S.
- Jun 01, 2021: Occlutech takes important step towards approval in China
- Feb 24, 2021: Occlutech announces completion of patient enrolment in pilot study of Atrial Flow Regulator (AFR) in patients with heart failure
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Occlutech International AB Pipeline Products and Ongoing Clinical Trials Overview
- Occlutech International AB Pipeline Products by Equipment Type
- Occlutech International AB Pipeline Products by Indication
- Occlutech International AB Ongoing Clinical Trials by Trial Status
- Occlutech International AB, Key Facts
- Occlutech International AB, Major Products and Services
- Occlutech International AB Number of Pipeline Products by Development Stage
- Occlutech International AB Pipeline Products Summary by Development Stage
- Occlutech International AB Ongoing Clinical Trials by Trial Status
- Occlutech International AB Ongoing Clinical Trials Summary
- Dialysis Prosthesis Device - Product Status
- Dialysis Prosthesis Device - Product Description
- Occlutech Atrial Flow Regulator (AFR) Device - Product Status
- Occlutech Atrial Flow Regulator (AFR) Device - Product Description
- Occlutech Atrial Flow Regulator (AFR) Device - A Multicenter, International, Follow-up Study to Monitor the Efficacy and Safety of the Occlutech Atrial Flow Regulator in Heart Failure Patients
- Occlutech Atrial Flow Regulator (AFR) Device - Flow Regulation by Opening the SepTum in Patients with Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study
- Occlutech Atrial Flow Regulator (AFR) Device - Prospective, Non-randomized, Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients with Pulmonary Hypertension
- Occlutech Figulla Flex II ASD Occluder - Product Status
- Occlutech Figulla Flex II ASD Occluder - Product Description
- Occlutech Figulla Flex II ASD Occluder - Comparative Effectiveness of Three Devices for Transcatheter Closure of Atrial Septal Defects for Adults: A Pilot Study (Trio-ASD)
- Occlutech Figulla Flex II ASD Occluder - Study to Evaluate the Efficacy of Occlutech ASD Occluder in the Treatment of Atrial Septal Defects
- Occlutech Figulla Flex II PFO Occluder - Product Status
- Occlutech Figulla Flex II PFO Occluder - Product Description
- Occlutech Figulla Flex II PFO Occluder - Prospective Randomized Multi-center Controlled Clinical Investigation Comparing Patent Foramen Ovale (PFO) Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion
- Occlutech Figulla Flex UNI - Product Status
- Occlutech Figulla Flex UNI - Product Description
- Occlutech International AB, Key Employees
- Glossary
- Occlutech International AB Pipeline Products by Equipment Type
- Occlutech International AB Pipeline Products by Development Stage
- Occlutech International AB Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aiolos Medical AB
- Breas Medical AB
- AddBio AB
